Peptide Synthesis Reagent Manufacturer & Supplier

Highfine Biotech is the leader of the Chinese peptide synthesis reagent industry and an important global manufacturer and supplier of peptide synthesis reagents.

LEARN MORE...

Peptide Synthesis Reagent Manufacturer & Supplier

Highfine Biotech is the leader of the Chinese peptide synthesis reagent industry and an important global manufacturer and supplier of peptide synthesis reagents.

LEARN MORE...

PRODUCTS

We are committed to serving the front-end process of new drug R&D to cater to customer needs. We provide characteristic chemicals for global pharmaceutical R&D and API production companies. Our products consist of characteristic amide bonds, building blocks, protein reagents, Ionic liquids, PROTAC reagents, unnatural amino acids, pharmaceutical reagents of liposomes and lipid nanoparticles, Nucleotide reagents, etc.

Applications

There are many applications for pharmaceutical synthesis reagents, which are essential for the pharmaceutical industry. The two common ones are Liposomes and Peptide synthesis reagents...

HIGHFINE STRENGTH

By keeping up with the global R&D trend of innovative drugs and the market demand of CRO and CMO companies at home and abroad, we can provide highly cost-effective products for customers from all over the world and facilitate the global R&D and production of new drugs with a wholly owned subsidiary Suzhou Highfine Import & Export Co., Ltd. in Nov 2021 as the main body of the company's import and export business.

ABOUT HIGHFINE

High Quality, Fine Efficiency

Suzhou Highfine Biotech Co., Ltd.

Suzhou Highfine Biotech Co., Ltd.(stock code: 301393), established in 2003, is located in Suzhou High-tech Industrial Development Zone. It is a high-tech enterprise in Jiangsu province and provides characteristic chemicals for global pharmaceutical R&D and production companies. Our products are mainly used in the fields of polypeptide, nucleotide, and pharmaceutical synthesis. At present, more than 1500 kinds of products have been developed and produced.

LEARN MORE...

2003

Since 2023

3000+

Number of customers served

500+

Types of R&D products

14000 m²

Area of R&D center

NEWS

We will publish information about new things behind Highfine's products, services and solutions irregularly, and you can have a deeper understanding of our brand, culture, products, services and industry trends through the News Center.

A Novel Approach to Peptide Synthesis: Flow-Based Synthesis Utilising a Liquid Chromatography Platform

24/11/2025

Solid-phase synthesis technology has become one of the commonly employed methods for synthesising small nucleic acids and peptide drugs due to its straightforward operation and suitability for automation.

A Practical Green Amidation Strategy: Exploration and Application of TCFH-NMI in Aqueous Media

14/11/2025

The construction of amide bonds is prevalent in the synthesis of drug active molecules, natural products, and biomolecules. Consequently, highly efficient and reliable peptide condensation reagents are of paramount importance in organic synthesis. To...

Highly Efficient “Chiral Guardian”: ATD-DMAP

31/10/2025

The formation of ester and amide bonds represents two crucial reactions in organic synthesis, being widely present in drug active molecules, natural products, and biomacromolecules. However, traditional condensation reagents suffer from issues such...

Successful Finale | Highfine Biotech Achieves Great Results at CPHI Frankfurt 2025

31/10/2025

The grand event concludes with fruitful results. The three-day global flagship event for the pharmaceutical industry — CPHI Frankfurt 2025 — successfully concluded on October 30 (local time, Germany).

CONTACT US

Please fill out the form below and our sales team will be happy to assist you with a quote on peptide synthesis reagents.

Thank you! Your message has been sent.
Unable to send your message. Please fix errors then try again.
Contact

Search

Popular Products: TBTU, HBTU, HOBT, HOPO

Leave a message

Thank you for visiting us. Please leave a message and we will reply by email.

Contact